Journal
ATHEROSCLEROSIS
Volume 204, Issue 2, Pages 359-364Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.atherosclerosis.2008.09.032
Keywords
Aneurysm; Apolipoprotein E; Chymase; Inhibitor; MMP-9; Mouse
Funding
- Science Research Promotion Fund
- High-Tech Research Center of the Promotion and Mutual Aid Corporation for Private School of Japan
Ask authors/readers for more resources
Objective: Chymase may play an important role in abdominal aortic aneurysm (AAA) development through matrix metalloproteinase (MMP)-9 activation. The purpose of this study was to determine whether chymase is involved in angiotensin (Ang) II-induced AAA development in apolipoprotein E (apoE)-deficient mice. Methods and results: In this study, Ang II (1000ng/kg/min; vehicle group) or saline (saline group) was administered to 16-week-old, male, apoE-deficient mice for 4 weeks. To examine the effects of chymase inhibition on AAA development, oral NK3201 (30 mg/kg/day) was given for the same period as the Ang 11 infusion. AAAs developed at the suprarenal region of the abdominal aorta in the Ang II-treated vehicle group, but they were not observed in the saline group. On the other hand, the severity and luminal area of the AAAs in the Ang II-treated vehicle group were significantly suppressed by NK3201 treatment. MMP-9 activity was significantly lower in the Ang II-treated + NK3201-treated group than in the Ang II-treated vehicle group. Furthermore, there were significantly fewer monocyte/macrophage cells in the Ang II-treated + NK3201-treated group than in the Ang II-treated vehicle group. Conclusions: Chymase is involved in Ang II-induced AAA development in apoE-deficient mice. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available